Gelmedix
Newton
About Gelmedix
Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. The company's platform offers a single non-invasive gel patch that can be used as a drug-eluting sealant with tissue adhesion, tunable drug elution, and biocompatibility properties, thereby enabling healthcare providers to reduce the usage of drops which cause inconvenience to patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $15.4M
- Funding stage: Seed
- Last round: Seed (Feb 2026)
- Website: gelmedix.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/gelmedix-69286 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.